---
input_text: 'Obstructive sleep apnea and craniofacial appearance in MPS type I-Hurler
  children after hematopoietic stem cell transplantation. OBJECTIVES: Mucopolysaccharidosis
  type I (MPS I) is an inherited lysosomal storage disorder characterized by severe
  multi-systemic organ manifestations including obstructive sleep apnea syndrome (OSAS).
  Hematopoietic stem cell transplantation (HSCT) is the treatment of choice in severe
  MPS I (MPS IH, Hurler syndrome). However, the effect of HSCT on OSAS in MPS IH still
  remains unclear. The purpose of this study was to analyze respiratory patterns during
  sleep following HSCT in MPS IH children and to relate these findings to craniofacial
  abnormalities. METHODS: Overnight polysomnographies of nine MPS IH children (mean
  age: 8.2 years) previously treated with HSCT were retrospectively analyzed. Magnetic
  resonance images of the head were assessed with regard to soft and hard tissue abnormalities
  of the upper respiratory tract. RESULTS: The mean apnea hypopnea index (AHI) was
  5.3 events/h (range, 0.3-12.2), and the majority of apnea/hypopneas were obstructive.
  Whereas two patients had severe OSAS (AHI > 10) and two moderate OSAS (5 > AHI <
  10), five patients had no evidence of OSAS (AHI < 2.0). Donor cell chimerism was
  significantly lower in MPS IH patients with OSAS as compared to patients without
  OSAS (p < 0.001). The upper airway space and the maxilla were significantly smaller
  and the adenoids larger in MPS IH patients with OSAS as compared to those of non-OSAS
  patients. CONCLUSION: OSAS was only observed in MPS IH patients with graft failure
  or low donor cell chimerism. Conversely, successful HSCT seems to ameliorate adenoid
  hyperplasia and maxillary constriction in MPS IH patients and thereby minimizes
  the risk of OSAS at least at younger ages.'
raw_completion_output: |-
  primary_disease: Mucopolysaccharidosis type I (MPS I)

  medical_actions: Hematopoietic stem cell transplantation (HSCT);Overnight polysomnographies;Magnetic resonance imaging

  symptoms: Obstructive sleep apnea syndrome (OSAS);Adenoid hyperplasia;Maxillary constriction;Graft failure;Low donor cell chimerism

  chemicals: 

  action_annotation_relationships: Hematopoietic stem cell transplantation (HSCT) TREATS obstructive sleep apnea syndrome (OSAS) IN Mucopolysaccharidosis type I (MPS I);Hematopoietic stem cell transplantation (HSCT) TREATS adenoid hyperplasia IN Mucopolysaccharidosis type I (MPS I);Hematopoietic stem cell transplantation (HSCT) TREATS maxillary constriction IN Mucopolysaccharidosis type I (MPS I);Hematopoietic stem cell transplantation (HSCT) PREVENTS graft failure IN Mucopolysaccharidosis type I (MPS I);Hematopoietic stem cell transplantation (HSCT) PREVENTS low donor cell chimerism IN Mucopolysaccharidosis type I (MPS I)
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Hematopoietic stem cell transplantation (HSCT) PREVENTS low donor cell chimerism IN Mucopolysaccharidosis type I (MPS I)

  ===

extracted_object:
  primary_disease: MONDO:1012617
  medical_actions:
    - MAXO:0000747
    - Overnight polysomnographies
    - Magnetic resonance imaging
  symptoms:
    - HP:0002870
    - Adenoid hyperplasia
    - Maxillary constriction
    - Graft failure
    - Low donor cell chimerism
  action_annotation_relationships:
    - subject: MAXO:0000747
      predicate: <TREATS>
      object: HP:0002870
      qualifier: MONDO:1012617
      subject_qualifier: <>
      object_qualifier: <>
      subject_extension: <Hematopoietic stem cell>
      object_extension: <obstructive sleep apnea>
    - subject: MAXO:0000747
      predicate: TREATS
      object: adenoid hyperplasia
      qualifier: MONDO:1012617
      subject_extension: Hematopoietic stem cell transplantation
    - subject: <Hematopoietic stem cell transplantation>
      predicate: <TREATS>
      object: <maxillary constriction>
      qualifier: <Mucopolysaccharidosis type I>
      subject_qualifier: <>
      object_qualifier: <>
      subject_extension: <Hematopoietic stem cell>
      object_extension: <>
    - subject: MAXO:0000747
      predicate: PREVENTS
      object: graft failure
      qualifier: MONDO:0001586
    - subject: MAXO:0000747
      predicate: <PREVENTS>
      object: <low donor cell chimerism>
      qualifier: MONDO:1012617
      subject_extension: <Hematopoietic stem cell>
named_entities:
  - id: MONDO:0001586
    label: mucopolysaccharidosis type I
  - id: MONDO:1012617
    label: Mucopolysaccharidosis Type I (MPS I)
  - id: CHEBI:60285
    label: DOPE
  - id: MAXO:0001521
    label: nasal administration
  - id: MONDO:0011758
    label: Mucopolysaccharidosis type I Hurler (MPSIH)
  - id: MAXO:0000747
    label: hematopoietic stem cell transplantation (HSCT)
  - id: MAXO:0000487
    label: clinical assessment (growth measurement, kyphosis and genu velgum evaluation)
  - id: HP:0002808
    label: kyphosis
  - id: HP:0001376
    label: limited joint mobility
  - id: HP:0008807
    label: acetabular dysplasia
  - id: MAXO:0010034
    label: Corneal transplantation
  - id: HP:0007957
    label: Corneal clouding
  - id: MAXO:0000149
    label: Hematopoietic cell transplantation (HCT)
  - id: HP:0000238
    label: Hydrocephalus
  - id: MAXO:0000068
    label: transplantation
  - id: MAXO:0000004
    label: surgery
  - id: MAXO:0000526
    label: clinical examination
  - id: CHEBI:143889
    label: glycosaminoglycan (GAG)
  - id: HP:0004322
    label: short stature
  - id: HP:0005619
    label: thoracolumbar kyphosis
  - id: HP:0000943
    label: dysostosis multiplex
  - id: MONDO:0011759
    label: Hurler-Scheie syndrome
  - id: HP:0001387
    label: joint stiffness
  - id: HP:0000403
    label: recurrent otitis media
  - id: HP:0001999
    label: facial dysmorphism
  - id: HP:0002781
    label: Upper airway obstruction
  - id: HP:0001638
    label: Cardiomyopathy
  - id: MAXO:0001479
    label: Allogeneic hematopoietic stem cell transplantation
  - id: MAXO:0001001
    label: Gene therapy
  - id: CHEBI:58187
    label: Alginate
  - id: CHEBI:53412
    label: PLL (Poly-L-lysine)
  - id: CHEBI:50594
    label: Carbon nanotubes
  - id: HP:0007663
    label: Reduced visual acuity
  - id: MAXO:0000016
    label: cellular therapy
  - id: CHEBI:19226
    label: Tm
  - id: MONDO:0017385
    label: mucopolysaccharidosis type I (MPSI) Hurler
  - id: MAXO:0000018
    label: Biomarker assessment
  - id: HP:0001138
    label: Optic neuropathy
  - id: HP:0000488
    label: Retinopathy
  - id: MONDO:0019052
    label: Inborn errors of metabolism
  - id: CHEBI:28901
    label: Busulfan
  - id: CHEBI:33310
    label: MCT (NE)
  - id: HP:0001367
    label: joint disease
  - id: HP:0002652
    label: skeletal dysplasia
  - id: HP:0000618
    label: vision impairments
  - id: HP:0000365
    label: hearing impairments
  - id: MONDO:0007147
    label: Obstructive sleep apnea syndrome (OSAS)
  - id: MAXO:0000915
    label: Overnight polysomnography (PSG)
  - id: HP:0002104
    label: Apnea
  - id: HP:0040213
    label: Hypopnea
  - id: MAXO:0010033
    label: Umbilical cord blood transplantation
  - id: MONDO:0009290
    label: Pompe Disease
  - id: HP:0005162
    label: Left ventricular failure
  - id: HP:0011675
    label: Conduction abnormalities
  - id: HP:0001677
    label: Coronary artery disease
  - id: HP:0001433
    label: Hepatosplenomegaly
  - id: HP:0033126
    label: Necrosis
  - id: CHEBI:46793
    label: 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-(amino[polyethylene glycol]-
      2000) (DSPE-PEG)
  - id: CHEBI:17754
    label: Glycerol
  - id: CHEBI:15377
    label: Water
  - id: CHEBI:27881
    label: Resveratrol
  - id: HP:0010864
    label: severe mental retardation
  - id: CHEBI:82467
    label: Evans blue
  - id: MONDO:0006249
    label: mucopolysaccharidoses (MPS)
  - id: CHEBI:232920
    label: Alginate-poly-L-lysine-alginate (APA)
  - id: HP:0000708
    label: Behavioral abnormalities
  - id: HP:0033429
    label: Neuroinflammation
  - id: MAXO:0001525
    label: Intravenous administration
  - id: HP:6000847
    label: cardiac mass
  - id: HP:0012393
    label: Allergic reactions
  - id: HP:0001268
    label: Cognitive decline
  - id: HP:0000388
    label: Otitis media
  - id: HP:0000750
    label: Language delays
  - id: MAXO:0000479
    label: Orthopedic surgeries
  - id: HP:0011947
    label: Respiratory infections
  - id: CHEBI:28088
    label: Genistein
  - id: MAXO:0000506
    label: Non-invasive ventilation
  - id: HP:0002091
    label: Restrictive lung disease
  - id: HP:0001513
    label: Obesity
  - id: HP:0000822
    label: High blood pressure
  - id: HP:0001626
    label: Cardiovascular abnormalities
  - id: CHEBI:18376
    label: dermatan sulfate
  - id: CHEBI:28815
    label: heparan sulfate
  - id: CHEBI:37397
    label: chondroitin sulfate
  - id: CHEBI:15971
    label: heparan sulfate (HS)
  - id: CHEBI:17053
    label: dermatan sulfate (DS)
  - id: CHEBI:16991
    label: DNA
  - id: HP:0001385
    label: Hip dysplasia
  - id: HP:0001263
    label: Cognitive delay
  - id: CHEBI:50693
    label: Milrinone
  - id: MAXO:0000011
    label: Physical therapy
  - id: HP:0003423
    label: Thoracolumbar kyphoscoliosis
  - id: HP:0002970
    label: Genua vara
  - id: HP:0002650
    label: Scoliosis
  - id: HP:0002857
    label: Genua valga
  - id: HP:0003311
    label: Odontoid hypoplasia
  - id: HP:0100543
    label: cognitive impairment
  - id: HP:0002180
    label: neurodegeneration
  - id: CHEBI:50803
    label: nanoparticles
  - id: HP:0002176
    label: spinal cord compression
  - id: HP:0012531
    label: pain (injection site, back, groin)
  - id: HP:0002315
    label: headache
  - id: HP:0033482
    label: limited shoulder flexion
  - id: HP:0004349
    label: decreased bone mineral density
  - id: HP:0000924
    label: skeletal anomalies
  - id: HP:0002240
    label: hepatomegaly
  - id: HP:0010619
    label: correlation of reaction time with fractional anisotropy (FA) in frontal
      and parietal white matter
  - id: HP:0003541
    label: Urinary glycosaminoglycan (GAG) excretion
  - id: HP:0002870
    label: Obstructive sleep apnea syndrome (OSAS)
